Introducing New ACTICOAT Flex

Introducing New ACTICOAT* Flex

ACTICOAT Flex has been designed to offer a highly conformable interface between the site of injury and secondary dressing. Protection is also provided through sustained antimicrobial performance.

Maintains contact with the wound bed even in awkward anatomical areas. Kills pathogenic organisms common to wounds in order to reduce the risk of infection. 1 Provides comfort for the patient during wear and allows them to move with the dressing still in place. 6 May be used to complement negative pressure wound therapy protocols. 3

Evidence

1. ACTICOAT Flex is soft and highly flexible with stretch properties Moves with the patient when they need to move the affected body part. 6 Minimises discomfort for the patient. Can be removed without causing trauma to the wound bed 4.

2. ACTICOAT Flex allows fluid transport into the secondary dressing to minimise the risk of maceration. ⁵

Demand Absorbency   Absorbency (g) Time (s)       EXU-DRY*   EXU-DRY + ACTICOAT   EXU-DRY + Silverlon™   EXU-DRY + ACTICOAT Flex 7

3. ACTICOAT Flex Provides sustained (3 or 7 day) antimicrobial activity against a broad spectrum of wound pathogens including MRSA & Pseudomonas aeruginosa ¹

Removes the barrier to healing thus allowing the patient to regain control and progress the wound to healing.

Mean log reduction (log10 cfu/ sample)

Figure 1. Antimicrobial activity measured by log reduction of ACTICOAT Flex 7 against common pathogenic wound pathogens over a 24 hour period (mean results, n= 3)

4. ACTICOAT Flex Rapidly kills bacteria in as little as thirty minutes ².

Antibacterial action helps provide rapid protection from bacterial colonisation and aids in the prevention of resistance.

Figure 2. Antimicrobial activity measured by log reduction of ACTICOAT Flex 3 against S. aureus and P. aeruginosa at 30 minutes (mean results, n=3)

Available with either 7 day or 3 day wear time

ACTICOAT Flex is available with either 7 day (ACTICOAT Flex 7) or 3 day (ACTICOAT Flex 3) wear time.

There is a range of sizes to suit a range of indications.

Ordering codes

References

1. Smith and Nephew Data on Files ref. 0901003. Antimicrobial activity of ACTICOAT Flex 7 against pathogenic
wound pathogens. (In-vitro data)
2. Smith and Nephew Data on File ref. 0810018. ACTICOAT Flex 3 has antimicrobial activity in 30 minutes. (In-vitro data)
3. Smith and Nephew Data on File ref. 0810015. To show efficacy of ACTICOAT Flex in combination with NPWT (In-vitro data)
4. Smith and Nephew expert statement. ACTICOAT wound bed preparation and wound trauma.
5. Smith and Nephew Data on File ref 0809009, Demand absorbency.
6. Smith and Nephew report ref. DS.08.123.R1